Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nicholas Koullas

Surgery Atlanta, GA Medical Doctor

NPI 1407415672 CMS profile 6399505

1365 Clifton Rd Ne, Bldg A Flr 2, Atlanta, GA 30322

Open in the dashboard

General payments

$11,019

169 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicholas Koullas of Atlanta, GA is reported in the CMS Open Payments database as having received $11,019 across 169 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,925 23
2024 General $1,576 23
2023 General $1,973 35
2022 General $2,175 51
2021 General $931 24
2020 General $416 12
2019 General $24 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Koullas
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Nicholas Koullas were reported at $3,925. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Nicholas Koullas Surgery median Middle half National median
2019 $24 $253 $82–$1,521 $163
2020 $416 $131 $40–$706 $114
2021 $931 $168 $50–$904 $132
2022 $2,175 $224 $76–$1,218 $149
2023 $1,973 $253 $82–$1,255 $160
2024 $1,576 $279 $90–$1,381 $164
2025 $3,925 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $5,782 79 payments
  2. Intuitive Surgical, Inc. $2,020 7 payments
  3. DePuy Synthes Sales Inc. $1,290 24 payments
  4. Acell, Inc. $299 5 payments
  5. Zimmer Biomet Holdings, Inc. $257 4 payments
  6. Davol Inc. $170 2 payments
  7. Kerecis Limited $170 2 payments
  8. Allergan Inc. $133 6 payments
  9. Avita Medical Americas, LLC $107 1 payment
  10. Aroa Biosurgery Incorporated $104 7 payments
  11. Other $686 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,414 163 payments
  2. Education $1,750 1 payment
  3. Long term medical supply or device loan $640 2 payments
  4. Travel and Lodging $215 3 payments
Products named General payments · program years 2019–2025
  1. Integra Recon-Skin And Wound $4,335 62 payments
  2. Integra Recon-Skin And Wound $4,103 58 payments
  3. Integra Recon-Skin And Wound $4,103 58 payments
  4. PRIMATRIX $4,074 57 payments
  5. INTEGRA DERMAL REGENERATION TEMPLATE $4,074 57 payments
  6. DAVINCI XI $1,750 1 payment
  7. MATRIXRIB $1,164 23 payments
  8. CYTAL Recon-Skin And Wound $769 13 payments
  9. CYTAL Recon-Skin And Wound $683 11 payments
  10. Cytal Recon-Skin And Wound $481 3 payments
  11. Other $3,329 80 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

169 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record